Login here
Register Free
Webinars
OCT 10, 2023 10:00 AM PDT

From Tissue to Insight: Genomic Testing Methodologies and Practical Considerations for Personalized Cancer Care

Sponsored by: Labcorp Oncology
C.E. Credits: P.A.C.E. CE ｜ Florida CE
Speakers
  • Kyle Strickland, MD, PhD

    Kyle Strickland, MD, PhD

    Labcorp Oncology, Director, Medical Affairs and Adjunct Associate Professor, Duke University Medical Center, Duke Cancer Institute, Department of Pathology
    BIOGRAPHY
  • Rebecca Previs, MD

    Rebecca Previs, MD

    Labcorp Oncology, Director, Medical Affairs and Adjunct Assistant Professor, Duke University Medical Center, Duke Cancer Institute, Department of Obstetrics & Gynecology, Division of Gynecologic Oncology
    BIOGRAPHY
Abstract
For patients with advanced non-small cell lung cancer (NSCLC), tissue samples are typically small biopsies. These samples undergo standard of care evaluation for >10 biomarkers to identify targeted, personalized therapies. If only single-gene tests are ordered, it is unlikely all biomarkers will be successfully tested.  Furthermore, the patient may not be able to get a second biopsy for comprehensive testing. Ordering single-gene tests before comprehensive profiling creates longer wait times for results, which can be problematic for selecting optimal treatment.
 
Join Drs. Kyle C. Strickland and Rebecca A. Previs from Labcorp Oncology’s Medical Affairs team for this webinar to hear about tissue stewardship from a pathologist and oncologist’s perspectives. We will review our latest data from advanced NSCLC which demonstrate that single-gene testing, if performed prior to comprehensive genomic profiling, doubles comprehensive genomic profiling failures due to tissue insufficiency and DNA extraction failures. We will share best practices to optimize tissue utilization and ensure patients with advanced NSCLC receive all recommended biomarker testing.
 
Participants of this session will:
  • Describe the various tissue testing methodologies available for evaluation of biomarkers for patients with advanced NSCLC.
  • Compare biomarker testing paradigms with single gene testing and comprehensive genomic profiling to describe benefits and pitfalls of each strategy.
  • Integrate best practices for tissue stewardship to optimize biomarker testing in advanced NSCLC.
 
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
 
Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

 

 

You May Also Like
DEC 10, 2024 | 9:00 AM
Expanding Proteomic Horizons with Single-Molecule Proteome Analysis
Expanding Proteomic Horizons with Single-Molecule Proteome Analysis
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
Speaker: Parag Mallick, Ph.D.
Sponsored By: Nautilus Biotechnology
OCT 02, 2024 | 7:30 AM
Accelerate Discovery and Development by Optimizing the Protein Engineering Workflow
Accelerate Discovery and Development by Optimizing the Protein...
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Speaker: Claudia Chiocchini
Presented at: Cancer Research & Oncology Virtual Event Series 2024
Sponsored By: Thermo Fisher Scientific
Loading Comments...
Content Tags
See more
Attendees
Resources